BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35598497)

  • 21. Availability of consumer prices from US hospitals for a common surgical procedure.
    Rosenthal JA; Lu X; Cram P
    JAMA Intern Med; 2013 Mar; 173(6):427-32. PubMed ID: 23400757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.
    Hart SA; Khan A; Booth GS; Wiencek JR
    Am J Clin Pathol; 2024 May; ():. PubMed ID: 38733607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Price Transparency and Compliance With Federal Regulation for Pediatric Tonsillectomy.
    Ayoub NF; Balakrishnan K
    Otolaryngol Head Neck Surg; 2022 Aug; 167(2):248-252. PubMed ID: 34546823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large variations in hospital pricing for standard procedures revealed.
    Shen C; Moss JL
    BMC Res Notes; 2022 Apr; 15(1):129. PubMed ID: 35382890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Price Variation in Coronary Artery Bypass Surgery at US Hospitals.
    Wei C; Paranjpe I; Sharma P; Milligan M; Lam M; Heidenreich PA; Kalwani N; Schulman K; Sandhu A
    J Am Heart Assoc; 2024 Feb; 13(4):e031982. PubMed ID: 38362880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ongoing Challenges With Price Transparency in Hospital Charges for Hand Procedures.
    Rhee BS; Kalliainen LK
    J Hand Surg Am; 2023 Dec; 48(12):1263-1267. PubMed ID: 37676189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Publicly Disclosed Pricing for Common Upper-Extremity Procedures: An Analysis of Hospital Chargemasters.
    Ozdag Y; Hayes DS; Boualam B; Foster BK; Klena JC; Grandizio LC
    Hand (N Y); 2023 Feb; ():15589447221150522. PubMed ID: 36760038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Price Transparency for Cervical Spinal Fusion Among High-Performing Spine Centers in the United States.
    Yoon JS; Ng PR; Hoffman SE; Gupta S; Mooney MA
    Neurosurgery; 2023 Nov; ():. PubMed ID: 37982614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.
    Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
    JAMA Surg; 2023 Feb; 158(2):152-160. PubMed ID: 36515928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in Payer-Negotiated Prices for Head and Neck Reconstructive Surgery.
    Wu SS; Rathi VK; Byrne PJ; Fritz MA; Shaye DA; Lee LN; Sethi RKV; Lindsay RW; Xiao R
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1154-1162. PubMed ID: 37337449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures.
    Zhang Y; Cerullo M; Esposito A; Golla V
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1215-1222.e1. PubMed ID: 36351331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital Prices for Pediatric Tympanostomy Tube Placement and Adenotonsillectomy in 2021.
    Miller AL; Xiao R; Rathi VK; Wang AA; Rutter MJ; Hartnick CJ; Sethi RKV
    Laryngoscope; 2023 Apr; 133(4):948-955. PubMed ID: 35678243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
    Jiang JX; Polsky D; Littlejohn J; Wang Y; Zare H; Bai G
    J Gen Intern Med; 2022 Nov; 37(14):3577-3584. PubMed ID: 34902095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Private Payer-Negotiated Prices for Outpatient Otolaryngologic Surgery.
    Wang AA; Xiao R; Sethi RKV; Rathi VK; Scangas GA
    Otolaryngol Head Neck Surg; 2022 Aug; 167(2):262-265. PubMed ID: 34582305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate.
    Lu AJ; Chen EM; Vutam E; Brandt J; Sadda P
    Healthc (Amst); 2020 Sep; 8(3):100443. PubMed ID: 32919582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.
    Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH
    Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to Price and Quality Transparency in Health Care Markets.
    Rao P; Fischer SH; Vaiana ME; Taylor EA
    Rand Health Q; 2022 Jun; 9(3):1. PubMed ID: 35837511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between community social risk factors and regional hospital-reported cash, negotiated, and chargemaster prices for 14 common services.
    Chang E; Psek W
    BMC Health Serv Res; 2024 Mar; 24(1):299. PubMed ID: 38448915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule.
    Kong E; Ji Y
    JAMA Netw Open; 2023 Jun; 6(6):e2320694. PubMed ID: 37378982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance With Federal Price Transparency Rules and Cost Estimation at United States Hospitals With Neurosurgical Training Programs.
    Giantini-Larsen A; Pandey A; Abou-Mrad Z; Tata N; Barzilai O; Bilsky M; Newman WC
    Neurosurgery; 2024 Feb; ():. PubMed ID: 38345364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.